# How Natera (NTRA) compares with the whole market and its popular alternatives

> Source: EasyCompare research, https://easycompare.io/research/ntra
> Data as of October 20, 2026. Total returns include reinvested dividends. Past performance does not predict future results; nothing here is investment advice.

Built by QuantCommons' quantitative engine, this page is about relative opportunity, not data on NTRA alone. It places NTRA (Natera, Inc.) against 17 popular alternatives, its neighboring categories and the entire market of over 10,000 U.S.-listed stocks and ETFs, and surfaces what has done better on consistent outperformance, return for the risk taken, behavior in real market crashes and diversification. The result is a clearer view of where NTRA stands in the market, and of the alternatives worth a closer look.

Period covered: NTRA's full trading record, from July 2015 through September 2026. The crash tests reach back to 2000 using older funds and the S&P 500. All returns include reinvested dividends. Data as of October 20, 2026.

## Key findings

- **Right now:** Over the past 6 months, NTRA rose 95.4% against 9.1% for the S&P 500 and 11.2% for the Nasdaq 100. Its medical diagnostic peers were far apart over the past 6 months, from CDNA (CareDx, up 225%) to LH (Labcorp, up 20.6%).
- **Stock or market?:** NTRA's 54.6% gain over the past 3 months far outran its industry: the medical diagnostics ETF IDNA (iShares Genomics Immunology and Healthcare ETF) rose 32.0%. The S&P 500 rose 3.9%. Last month cut against the tape: NTRA rose 9.5% while the S&P 500 fell 0.6%.
- **Past 1 to 3 years:** NTRA has run far ahead of the market, rising 115% over the past year against 15.8% for the S&P 500 and 17.9% for the Nasdaq 100. The same gap shows up over 3 years (896% against 89.3%). The last two calendar years both went the same way: NTRA rose 44.7% in 2025, against 15.8% for the S&P 500 and 17.9% for the Nasdaq 100.
- **Long term:** NTRA turned $10,000 into $394,000 over the past decade, against $42,100 in the S&P 500. NTRA's 10-year return of 3,841% puts it ahead of 99% of the stocks worth at least $300 million with that much history. The S&P 500 returned 321%.
- **In a crash:** Across four sell-offs, NTRA has typically fallen 3.0 times as far as the S&P 500.
- **Diversification:** Over 10 years, NTRA's beta versus the S&P 500 was 1.40: in the S&P 500's rising months it gained 1.7 times as much as the index, and in falling months it lost 82% as much. NTRA is some diversification, but not a hedge: a correlation of 0.42 with the S&P 500 over 5 years and 0.44 with the total US market, more closely than 57% of stocks worth at least $300 million.
- **Better options:** Across the whole market, NTRA outpaced 99% of stocks worth at least $300 million over the past decade. Even so, across the whole market, 125 of the 3,633 stocks and funds worth at least $500 million earned more than NTRA with less volatility over the past 5 years, among them NVDA (NVIDIA), TSM (Taiwan Semiconductor Manufacturing) and AVGO (Broadcom).

## How much would $10,000 in NTRA have grown?

This chart tracks a hypothetical $10,000 investment in NTRA over the past 11 years, with dividends reinvested, alongside the same amount in the S&P 500, investments that ended ahead of NTRA over the same span and NTRA's popular alternatives, among those that traded for the entire period.

- $10,000 invested in NTRA at the end of September 2015 would have grown to $380,944 by September 2026, more than the $47,605 it would have become in SPY, an S&P 500 fund.
- Five of the eight other investments on the chart ended ahead of NTRA, and NVDA finished highest, at $3,837,604.

## NTRA at a glance

This section summarizes the key facts about the stock, its returns over periods from one to ten years and the risk it has carried, with dividends reinvested throughout.

- NTRA's deepest decline since it began trading in 2015 was 77.7%, from September 2021 to May 2022. It took 28 months from the low to climb back to its old high.
- Over ten full calendar years, NTRA's best was 2020, when it returned 195%, and its worst was 2022, when it lost 57.0%. It lost money in three of those years.
- NTRA is 4.6% below its all-time high.

- Type: Stock, Healthcare (Medical - Diagnostics & Research)
- Trading since: July 1, 2015
- Market value: $59B
- Volatility (5 years): 57.6%; Sharpe ratio: 0.74
- Worst decline ever: −77.7%, from September 17, 2021 to May 11, 2022; back at its high by September 13, 2024

| Period | NTRA total return |
| --- | --- |
| 1 month | +9.5% |
| 3 months | +54.6% |
| 6 months | +95.4% |
| year to date | +77.4% |
| 1 year | +115% |
| 3 years | +896% |
| 5 years | +261% |
| 10 years | +3,841% |

## NTRA against the whole market

Where NTRA ranks among every stock and fund, and what across the market has done better.

### How does NTRA rank among all stocks?

This section ranks NTRA on return, volatility, risk-adjusted return and worst decline against every stock worth at least $300 million with enough history.

- NTRA's 10-year return ranks in the top 1% of the 2,202 stocks worth at least $300 million with 10 years of history.
- NTRA is among the more volatile stocks: its price swings rank in the bottom 24% of the 2,893 stocks worth at least $300 million, where the top is the calmest.

| Measure | NTRA | Rank |
| --- | --- | --- |
| 1-year return | +115% | 135 of 3,287 (top 5%) |
| 3-year return | +896% | 34 of 3,017 (top 2%) |
| 5-year return | +261% | 213 of 2,893 (top 8%) |
| 10-year return | +3,841% | 12 of 2,202 (top 1%) |
| Volatility, 5 years | 57.6% | 2,206 of 2,893 (top 77%) |
| Sharpe ratio, 5 years | 0.74 | 388 of 2,893 (top 14%) |
| Worst decline, past 10 years | −77.7% | 1,554 of 2,187 (top 72%) |

### What has beaten NTRA on both return and risk?

Each dot is an investment, placed by how much it earned a year over the past 5 years (higher is better) and how much its price swung, its volatility (further left is calmer).

- 124 stocks and one ETF worth at least $500 million sit in the green region: each earned more than NTRA over the past 5 years with smaller price swings. That is 3% of the 3,633 screened.
- Among those with at least half NTRA's swings, FIX has the best return for its risk: 77.0% a year at 46.7% volatility, 19% less than NTRA's 57.6%, and a Sharpe ratio (return above cash per unit of volatility) of 1.46 against 0.74 for NTRA. BELFB earned the most, 78.0% a year, while still swinging less than NTRA (52.1% against 57.6%).

### Is there a better investment than NTRA?

The table below lists investments that beat NTRA over the past 5 years on at least one of these measures: a higher annual return with lower volatility, a higher annual return at similar volatility, a similar return with lower volatility, a higher Sharpe ratio with a smaller worst decline, a higher total return in most periods from 3 months to 10 years, or smaller losses in recent market crashes.

- Across the whole market, 125 of the 3,633 stocks and funds worth at least $500 million earned more than NTRA with less volatility over the past 5 years, among them NVDA, TSM and AVGO.

The 15 strongest of 125 investments that beat NTRA over the past 5 years, out of 3,633 stocks and funds worth at least $500 million.

| Investment | Group | Annual return (5 years) | Volatility | Sharpe | Worst decline (10 years) | 10Y return | Correlation with NTRA | Better on |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| NTRA: Natera, Inc. (this page) |  | +29.3% | 57.6% | 0.74 | −77.7% | +3,841% |  |  |
| [FIX](https://easycompare.io/research/fix): Comfort Systems USA, Inc. | Engineering & Construction | +77.0% | 46.7% | 1.46 | −49.7% | +5,305% | 0.33 | Higher return, lower volatility; Higher Sharpe, smaller worst decline; Smaller losses in recent crashes |
| [PBR-A](https://easycompare.io/research/pbr-a): Petróleo Brasileiro S.A. - Petrobras | Integrated Oil & Gas | +51.8% | 37.5% | 1.31 | −71.7% | +768% | -0.02 | Higher return, lower volatility; Higher Sharpe, smaller worst decline |
| [NVDA](https://easycompare.io/research/nvda): NVIDIA Corporation | Semiconductors | +58.0% | 51.9% | 1.14 | −66.3% | +13,019% | 0.22 | Higher return, lower volatility; Higher Sharpe, smaller worst decline |
| [HWM](https://easycompare.io/research/hwm): Howmet Aerospace Inc. | Aerospace & Defense | +47.3% | 32.5% | 1.36 | −68.9% | +1,028% | 0.29 | Higher return, lower volatility; Higher Sharpe, smaller worst decline |
| [CAH](https://easycompare.io/research/cah): Cardinal Health, Inc. | Health Care Distribution | +42.1% | 24.7% | 1.55 | −46.1% | +349% | 0.30 | Higher return, lower volatility; Higher Sharpe, smaller worst decline |
| [AVGO](https://easycompare.io/research/avgo): Broadcom Inc. | Semiconductors | +48.3% | 44.5% | 1.11 | −48.3% | +2,380% | 0.10 | Higher return, lower volatility; Higher Sharpe, smaller worst decline |
| [TSM](https://easycompare.io/research/tsm): Taiwan Semiconductor Manufacturing Company Limited | Semiconductors | +31.5% | 38.5% | 0.91 | −56.6% | +1,505% | 0.19 | Higher return, lower volatility; Higher Sharpe, smaller worst decline |
| [LLY](https://easycompare.io/research/lly): Eli Lilly and Company | Pharmaceuticals | +40.7% | 32.8% | 1.21 | −34.5% | +1,807% | 0.25 | Higher return, lower volatility; Higher Sharpe, smaller worst decline |
| [HSBC](https://easycompare.io/research/hsbc): HSBC Holdings plc | Banks | +33.1% | 25.9% | 1.24 | −62.3% | +319% | -0.13 | Higher return, lower volatility; Higher Sharpe, smaller worst decline |
| [CAT](https://easycompare.io/research/cat): Caterpillar Inc. | Industrial Machinery | +31.1% | 31.9% | 1.01 | −43.4% | +936% | 0.23 | Higher return, lower volatility; Higher Sharpe, smaller worst decline |
| [DELL](https://easycompare.io/research/dell): Dell Technologies Inc. | Computer Hardware | +55.2% | 54.4% | 1.08 | −59.6% | +3,701% | 0.09 | Higher return, lower volatility; Higher Sharpe, smaller worst decline |
| [MUFG](https://easycompare.io/research/mufg): Mitsubishi UFJ Financial Group, Inc. | Banks | +33.2% | 29.4% | 1.13 | −54.9% | +483% | 0.03 | Higher return, lower volatility; Higher Sharpe, smaller worst decline |
| [LRCX](https://easycompare.io/research/lrcx): Lam Research Corporation | Semiconductor Equipment | +37.4% | 49.9% | 0.89 | −56.4% | +2,989% | 0.33 | Higher return, lower volatility; Higher Sharpe, smaller worst decline |
| [ANET](https://easycompare.io/research/anet): Arista Networks, Inc. | Communications Equipment | +49.0% | 49.0% | 1.06 | −52.2% | +3,439% | 0.27 | Higher return, lower volatility; Higher Sharpe, smaller worst decline |
| [MCK](https://easycompare.io/research/mck): McKesson Corporation | Health Care Distribution | +38.7% | 25.0% | 1.44 | −38.1% | +586% | 0.05 | Higher return, lower volatility; Higher Sharpe, smaller worst decline |

## NTRA against its popular alternatives

The investments people most often weigh against NTRA, compared period by period and year by year.

### How do NTRA's risk and return compare with its alternatives?

This map plots each investment's annual return over the past 5 years against its volatility, the size of its typical price swings.

- None of the 17 popular alternatives earned more than NTRA over the past 5 years with smaller price swings, so every higher return on the map came with a bumpier ride.
- Nine of the 17 popular alternatives earned less than NTRA over the past 5 years while swinging more, the weaker corner of the map.
- Over the past 5 years, NTRA returned 29.3% a year, more than the S&P 500's 12.7%, with higher volatility (57.6% against 17.1%).

### Has NTRA consistently beaten its popular alternatives?

This section compares NTRA with the investments people most often weigh against it, checking each one over eight periods from one month to ten years.

- None of the 17 popular alternatives outperformed NTRA in at least 3 of 5 short-term and 2 of 3 long-term timeframes. The closest was CDNA.

| Investment | 1Y return | 3Y return | 5Y return | 10Y return | Periods ahead of NTRA | Verdict | Sharpe |
| --- | --- | --- | --- | --- | --- | --- | --- |
| NTRA: Natera, Inc. (this page) | +115% | +896% | +261% | +3,841% |  |  | 0.74 |
| CDNA: CareDx, Inc | +355% | +1,203% | −3.8% | +1,634% | 5/5 short-term, 1/3 long-term |  | 0.39 |
| PSNL: Personalis, Inc. | +57.5% | +1,582% | −18.7% | — | 2/5 short-term, 1/3 long-term |  | 0.45 |
| [ILMN](https://easycompare.io/research/ilmn): Illumina, Inc. | +169% | +130% | −33.3% | +93.0% | 4/5 short-term, 0/3 long-term |  | 0.06 |
| TXG: 10x Genomics, Inc. | +444% | +81.2% | −55.8% | — | 4/5 short-term, 0/3 long-term |  | 0.12 |
| NEO: NeoGenomics, Inc. | +56.9% | +19.6% | −62.6% | +114% | 1/5 short-term, 0/3 long-term |  | 0.07 |
| MYGN: Myriad Genetics, Inc. | −29.9% | −63.2% | −83.0% | −71.7% | 1/5 short-term, 0/3 long-term |  | -0.16 |
| PACB: Pacific Biosciences of California, Inc. | −1.0% | −73.5% | −92.2% | −77.9% | 1/5 short-term, 0/3 long-term |  | -0.04 |
| GH: Guardant Health, Inc. | +132% | +534% | +52.8% | — | 1/5 short-term, 0/3 long-term |  | 0.46 |
| RGEN: Repligen Corporation | +15.8% | +22.5% | −33.3% | +514% | 0/5 short-term, 0/3 long-term |  | 0.10 |
| VCYT: Veracyte, Inc. | +22.2% | +114% | −3.6% | +451% | 0/5 short-term, 0/3 long-term |  | 0.31 |
| [TMO](https://easycompare.io/research/tmo): Thermo Fisher Scientific Inc. | +26.8% | +49.5% | +15.1% | +366% | 0/5 short-term, 0/3 long-term |  | 0.24 |
| DGX: Quest Diagnostics Incorporated | +26.5% | +103% | +78.5% | +243% | 0/5 short-term, 0/3 long-term |  | 0.63 |
| [DHR](https://easycompare.io/research/dhr): Danaher Corporation | +8.3% | +10.8% | −17.6% | +232% | 0/5 short-term, 0/3 long-term |  | 0.01 |
| LH: Labcorp Holdings Inc. | +12.2% | +67.4% | +42.4% | +184% | 0/5 short-term, 0/3 long-term |  | 0.42 |
| QGEN: Qiagen N.V. | +6.3% | +45.9% | +3.0% | +111% | 0/5 short-term, 0/3 long-term |  | 0.15 |
| [BDX](https://easycompare.io/research/bdx): Becton, Dickinson and Company | +32.3% | +1.6% | +12.2% | +71.4% | 0/5 short-term, 0/3 long-term |  | 0.22 |
| ADPT: Adaptive Biotechnologies Corporation | +37.0% | +493% | −28.0% | — | 0/5 short-term, 0/3 long-term |  | 0.30 |

### How did NTRA do year by year?

This table shows each investment's total return in every full calendar year since 2016, along with where NTRA ranked among its popular alternatives each year.

- NTRA finished ahead of the S&P 500 in six of its ten full calendar years, and ahead of it in each of the last three.
- Ranked against its popular alternatives each year, NTRA finished in the top quarter in six of ten years and in the bottom quarter in one. In 2025, it ranked 3 of 18.
- None of the 17 popular alternatives came out ahead of NTRA in most of the years they have in common.

| Year | NTRA | SPY |
| --- | --- | --- |
| 2025 | +44.7% | +17.7% |
| 2024 | +153% | +24.9% |
| 2023 | +55.9% | +26.2% |
| 2022 | −57.0% | −18.2% |
| 2021 | −6.2% | +28.7% |
| 2020 | +195% | +18.3% |
| 2019 | +141% | +31.2% |
| 2018 | +55.3% | −4.6% |
| 2017 | −23.2% | +21.7% |
| 2016 | +8.4% | +12.0% |

## Risk and diversification

How NTRA has fallen, how it held up in crashes beside the S&P 500 and its popular alternatives, and what moves independently of it.

### What were NTRA's worst declines?

A drawdown is the decline from a peak to the lowest point before a new high.

- In all five of NTRA's worst declines, the S&P 500 held up better over the same dates.
- Not every decline was the market's doing: NTRA fell 30.8% from February to May 2021, while the S&P 500 rose 6.0%.
- The slowest recovery came after NTRA fell 70.0% from July 2015 to February 2016; it did not regain that peak until July 2018, two years later.

| Decline | Peak | Low | Back at the high | SPY over the same dates | Market event |
| --- | --- | --- | --- | --- | --- |
| −77.7% | September 17, 2021 | May 11, 2022 | September 13, 2024 | −10.4% | 2022 bear market |
| −70.0% | July 6, 2015 | February 8, 2016 | July 16, 2018 | −9.3% | 2015 China and oil sell-off |
| −60.8% | August 24, 2018 | January 9, 2019 | August 8, 2019 | −9.3% | late-2018 sell-off |
| −57.3% | November 19, 2019 | March 18, 2020 | May 7, 2020 | −22.7% | Covid crash |
| −30.8% | February 12, 2021 | May 21, 2021 | September 17, 2021 | +6.0% |  |

### How did NTRA do in stock market crashes?

This section measures how far NTRA, the S&P 500 and each alternative fell from peak to trough during every major market crash since 2000.

- NTRA fell further than the S&P 500 in all six crashes it has traded through. The clearest case was the 2015 China and oil sell-off, when NTRA fell 61.5% and the S&P 500 fell 12.8%.
- Among its popular alternatives, MYGN held up best, falling less than NTRA in all six crashes they both traded through.
- NTRA began trading after the 2008 financial crisis, but ten of its popular alternatives lived through it. The mildest fall among them was DGX's 29.2%, against 55.2% for the S&P 500.

| Crash | Dates | NTRA fall | SPY fall |
| --- | --- | --- | --- |
| Dot-com bust | March 10, 2000 to October 9, 2002 | not trading | −47.5% |
| Global financial crisis | October 9, 2007 to March 9, 2009 | not trading | −55.2% |
| Flash crash | May 6, 2010 to May 7, 2010 | not trading | −1.5% |
| Euro debt crisis | July 22, 2011 to October 3, 2011 | not trading | −17.9% |
| China devaluation & oil rout | August 10, 2015 to February 11, 2016 | −61.5% | −12.8% |
| Volmageddon | February 2, 2018 to February 9, 2018 | −11.2% | −6.5% |
| Q4 2018 selloff | September 21, 2018 to December 24, 2018 | −51.1% | −19.3% |
| COVID crash | February 19, 2020 to March 23, 2020 | −57.0% | −33.7% |
| 2022 bear market | January 4, 2022 to October 12, 2022 | −68.0% | −24.5% |
| SVB / regional bank stress | March 8, 2023 to March 13, 2023 | −6.2% | −3.4% |

### How closely does NTRA move with the S&P 500?

Upside capture measures how much of the S&P 500's gains an investment kept in the months the market rose, and downside capture how much of its losses it took in the months the market fell.

- None of the 13 popular alternatives with the same record had a higher capture ratio (upside capture divided by downside capture) than NTRA's 2.06.
- Over the past 10 years, NTRA captured 169% of the S&P 500's gains in rising months and 82% of its losses in falling months, with a beta of 1.40. Its share of the market's gains was larger than its share of the losses.

Measured over the past 10 years of monthly returns against SPY.

| Investment | Upside capture | Downside capture | Beta |
| --- | --- | --- | --- |
| NTRA: Natera, Inc. (this page) | 169% | 82.0% | 1.40 |
| CDNA: CareDx, Inc | 186% | 161% | 1.56 |
| [ILMN](https://easycompare.io/research/ilmn): Illumina, Inc. | 120% | 200% | 1.19 |
| NEO: NeoGenomics, Inc. | 116% | 169% | 1.26 |
| MYGN: Myriad Genetics, Inc. | 68.0% | 233% | 1.63 |
| PACB: Pacific Biosciences of California, Inc. | 76.0% | 234% | 1.70 |
| RGEN: Repligen Corporation | 119% | 108% | 0.99 |
| VCYT: Veracyte, Inc. | 128% | 128% | 1.41 |
| [TMO](https://easycompare.io/research/tmo): Thermo Fisher Scientific Inc. | 104% | 104% | 0.81 |
| DGX: Quest Diagnostics Incorporated | 69.0% | 54.0% | 0.80 |
| [DHR](https://easycompare.io/research/dhr): Danaher Corporation | 84.0% | 84.0% | 0.75 |
| LH: Labcorp Holdings Inc. | 81.0% | 91.0% | 0.97 |
| QGEN: Qiagen N.V. | 62.0% | 83.0% | 0.45 |
| [BDX](https://easycompare.io/research/bdx): Becton, Dickinson and Company | 53.0% | 77.0% | 0.48 |

### What diversifies NTRA?

Correlation measures how closely two investments move together, on a scale from 1 (in lockstep) through 0 (unrelated) to -1 (in opposite directions).

- Moving a fifth of the money in NTRA into GLD would have cut the portfolio's volatility by 20% over the past 5 years and raised its annual return (+30.0% for NTRA alone, +31.0% for the mix).
- MCK made money in three of the three calendar years in which NTRA lost money.
- Among large ETFs, LVHI, DXJ and EMLP have moved largely independently of NTRA over the past 5 years, with correlations of 0.17 or lower, and each still earned a positive 5-year return.

| Investment | Correlation with NTRA | 5Y return | Volatility | Sharpe | Rose in NTRA's 3 down years |
| --- | --- | --- | --- | --- | --- |
| LVHI: Franklin International Low Volatility High Dividend Index ETF | 0.11 | +119% | 11.1% | 1.48 | 3 of 3 |
| DXJ: WisdomTree Japan Hedged Equity Fund | 0.17 | +225% | 19.1% | 1.34 | 3 of 3 |
| EMLP: First Trust North American Energy Infrastructure Fund | 0.17 | +101% | 14.5% | 1.04 | 3 of 3 |
| HDV: iShares Core High Dividend ETF | 0.13 | +83.3% | 13.0% | 1.00 | 3 of 3 |
| [SMH](https://easycompare.io/research/smh): VanEck Semiconductor ETF | 0.33 | +323% | 36.9% | 0.97 | 2 of 3 |
| DBEF: Xtrackers MSCI EAFE Hedged Equity ETF | 0.31 | +85.0% | 13.8% | 0.96 | 2 of 3 |
| [GLD](https://easycompare.io/research/gld): SPDR Gold Shares | -0.07 | +126% | 18.9% | 0.96 | 1 of 3 |
| SPMO: Invesco S&P 500 Momentum ETF | 0.43 | +136% | 20.8% | 0.93 | 2 of 3 |

## Common questions

### What was NTRA's worst drawdown?

NTRA's deepest decline since it began trading in 2015 was 77.7%, from September 2021 to May 2022. It took 28 months from the low to climb back to its old high. Because NTRA launched in July 2015, that record does not include the dot-com bust, the 2008 financial crisis or two other sell-offs.

### What were NTRA's best and worst years?

Over ten full calendar years, NTRA's best year was 2020, when it returned 195%. Its worst was 2022, with a return of -57.0%.

### Is there a better investment than NTRA?

Across the whole market, 125 of the 3,633 stocks and funds worth at least $500 million earned more than NTRA with less volatility over the past 5 years, among them NVDA, TSM and AVGO.

### Is NTRA more volatile than the S&P 500?

Yes. NTRA's volatility over the past 5 years was 57.6%, 3.4 times the S&P 500's 17.1%. Volatility measures how widely returns swing around their average: in roughly two years out of three, NTRA's return lands within 57.6% of its average, either way. The higher it is, the rougher the ride and the harder it is to hold through a slump.

### What is NTRA's Sharpe ratio?

NTRA's Sharpe ratio over the past 5 years was 0.74, against 0.79 for the S&P 500, so NTRA earned less for each unit of risk than an index fund did. The Sharpe ratio is the return earned above cash for each unit of volatility: two investments with the same return are not equal if one got there with far bigger swings.

### How correlated is NTRA with the S&P 500?

Over the past 5 years, NTRA's monthly returns had a correlation of 0.42 with the S&P 500. Correlation runs from 1 (moving in lockstep) through 0 (unrelated) to −1 (moving in opposite directions). They often move together: some diversification next to an index fund, but not a cushion. In the table, the correlation column measures each option against NTRA instead: the lower it is, the more that option would diversify a NTRA holding.

### What are the best alternatives to NTRA?

None of the 17 popular alternatives we compared outperformed NTRA in at least 3 of 5 short-term and 2 of 3 long-term timeframes, which says more about NTRA's strength than about its alternatives.

### Did NTRA outperform the S&P 500?

NTRA finished ahead of the S&P 500 (SPY) in six of ten full calendar years. In 2025, it returned +44.7%, against +17.7% for the index.

### How did NTRA do in stock market crashes?

NTRA fell less than the S&P 500 (SPY) in none of the six major crashes it has traded through, and further in six. The clearest case was the 2015 China and oil sell-off, when NTRA fell 61.5% and the S&P 500 fell 12.8%.

### What diversifies NTRA?

These had a low correlation with NTRA over the past 5 years and still earned a positive 5-year return: among large ETFs, LVHI (correlation 0.11), DXJ (correlation 0.17) and EMLP (correlation 0.17); among large stocks, CAH (correlation 0.30), CLS (correlation 0.22) and FIX (correlation 0.33). A correlation near zero means the two have moved largely independently.

## More research

- [Illumina (ILMN) Performance, Alternatives and Market Rank](https://easycompare.io/research/ilmn)
- [Thermo Fisher Scientific (TMO) Performance, Alternatives and Market Rank](https://easycompare.io/research/tmo)
- [Danaher (DHR) Performance, Alternatives and Market Rank](https://easycompare.io/research/dhr)
- [Becton, Dickinson and Company (BDX) Performance, Alternatives and Market Rank](https://easycompare.io/research/bdx)
- [Schwab U.S. Dividend Equity ETF (SCHD) Performance, Alternatives and Market Rank](https://easycompare.io/research/schd)
- [NVIDIA (NVDA) Performance, Alternatives and Market Rank](https://easycompare.io/research/nvda)
- [Apple (AAPL) Performance, Alternatives and Market Rank](https://easycompare.io/research/aapl)
- [Alphabet (GOOG) Performance, Alternatives and Market Rank](https://easycompare.io/research/goog)
- [Microsoft (MSFT) Performance, Alternatives and Market Rank](https://easycompare.io/research/msft)
- [Amazon.com (AMZN) Performance, Alternatives and Market Rank](https://easycompare.io/research/amzn)
- [Vanguard Morningstar Total Stock Market ETF (VTI) Performance, Alternatives and Market Rank](https://easycompare.io/research/vti)
- [Taiwan Semiconductor Manufacturing (TSM) Performance, Alternatives and Market Rank](https://easycompare.io/research/tsm)

## Explore further

- Full page with charts: https://easycompare.io/research/ntra
- All research pages: https://easycompare.io/llms.txt
- Compare the entire market against NTRA live: https://betterthanspy.com/?b=NTRA&utm_source=easycompare&utm_medium=research